Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2010, Pages

  Alberts, David S ^b   Brady, Mark ^b   Cikaric, Slobodan ^b   Chen, Hongwei ^b   Dinshaw, Ketayun ^b   Eifel, Patricia J ^b   Garipagaoglu, Melahat ^b   Jakobsen, Anders ^b   Kantardzic, Nermina ^b   Keys, Henry ^b   Lal, Punita ^b   Lanciano, Rachelle ^b   Leborgne, Felix ^b   Lorvidhaya, Vicharn ^b   Onishi, Hiroshi ^b   Karmar, Mahesh K B ^b   Pearcey, Robert G ^b   Pras, Elizabeth ^b   Roberts, Kenneth ^b   Rose, Peter G ^b   Stewart, Lesley A ^b   Tierney, Jayne F ^b   Thomas, Gillian ^b   Trimble, Ted ^b   Vale, Claire ^b   Whitney, Charles W ^b   Vale, C L ^a   more..

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; CISPLATIN; FLUOROURACIL; MITOMYCIN;

BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT PLANNING; UTERINE CERVIX CANCER; FEMALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MITOMYCIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 77950877038     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008285     Document Type: Review

References (59)

1. Chen HW, Jei J, Wei L. A randomized trial of hyperthermo-radiochemotherapy for uterine cancer. Chinese Journal of Oncology 1997;24:249-51.
2. Chen HW, Jei J, Wei L. A randomized trial of hyperthermo-radiochemotherapy for uterine cancer. Chinese Journal of Oncology 1997;24:249-51.
3. Cikaric S, Petrovic-Stupar S, Marjanov I, Rudan L, Colakovic S, Timasevic A, et al.Radiotherapy versus radiotherapy and chemotherapy of advanced cervical cancer: Regression of tumour, early and late sequalaes, relapses of disease and 3-years survival (the third phase).. European Journal of Cancer 2005;3 (Suppl):266.
4. Garipağaoğlu M, Kayikcioglu F, Kose MF, Adli M, Gulkesen KH, Koçak Z, et al.Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: A prospective randomized pilot study. British Journal of Cancer 2004;77:581-7.
5. Kantardzic N, Beslija S, Begic D. Comparison of parameters of myelotoxicity in patients treated with concomitant chemotherapy and radiotherapy versus radiotherapy alone. Medicinski Arhiv 2004;58:19-22.
6. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al.Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine 1999;340:1154-61.
7. Saibish Kumar E, Lal P, Tiwari A, Kumar S, Dimri K, Rastogi N, et al.Chemo-irradiation versus radiotherapy alone in locally advanced carcinoma of the uterine cervix: An onging phase III trial. Presented at the 23rd Annual Meeting of the European Society for Therapeutic Radiology and Oncology, Amsterdam, the Netherlands. October 24-28. 2004; Vol. Abstract 673.
8. Lanciano RM, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, et al.Randomized comparison of weekly cisplatin or protracted venous infusion of fluouracil in combination with pelvic radiation in advanced cervical cancer: A Gynecological Oncology Group study. Journal of Clinical Oncology 2005;23:8289-95.
9. Lanciano RM, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, et al.Randomized comparison of weekly cisplatin or protracted venous infusion of fluouracil in combination with pelvic radiation in advanced cervical cancer: A Gynecological Oncology Group study. Journal of Clinical Oncology 2005;23:8289-95.
10. Leborgne F. Unpublished.
11. Lorvidhaya V, Chitapanaraux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, et al.Concurrent mitomycin, 5-fluourouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. International Journal of Radiation Oncology Biology and Physics 2003;55:1226-32.
12. Lorvidhaya V, Chitapanaraux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, et al.Concurrent mitomycin, 5-fluourouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. International Journal of Radiation Oncology Biology and Physics 2003;55:1226-32.
13. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al.Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Oncology Group Trial (RTOG) 90-01. Journal of Clinical Oncology 2004;22:872-80.
14. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenbach C, Stevens RE, et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New England Journal of Medicine 1999;340:1137-43.
15. Onishi H, Yagamushi M, Kuriyama K, Tsukamoto T, Ishigame K, Ichikawa T, et al.Effet of concurrent intra-arterial infusion of platinum drugs for patients with stage III of IV uterine cervical cacner treated with radiotherapy. Cancer Journal of Scientific American 2000;6:40-5.
16. Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al.Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology 2002;20:966-72.
17. Peters WA III, Lui PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix. Journal of clinical oncology 2000;18:1606-13.
18. Pras E. Unpublished.
19. Roberts KB, Urdaneta N, Vera R, Vera A, Gutierrez E, Aguilar Y, et al.Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. International Journal of Cancer 2000;90:206-23.
20. Rose PG, Bundy BN, Watkins EB, Thigpen T, Deppe G, Maiman MA, et al.Concurent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340:1144-53.
21. Rose PG, Bundy BN, Watkins EB, Thigpen T, Deppe G, Maiman MA, et al.Concurent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340:1144-53.
22. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al.A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluourouracil in locally advanced cervical cancer. Gynecologic Oncology 1998;69:137-45.
23. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al.A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluourouracil in locally advanced cervical cancer. Gynecologic Oncology 1998;69:137-45.
24. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea in stage IIB/IVA carcinoma of the cervix. Journal of Clinical Oncology 1999;17:1339-48.
25. Bulnes R, Rivera R. Carcinoma of the uterine cervix: treatment with combined radiotherapy and chemotherapy [Carcinoma Epidermoide del cervix uterino: Tratamiento con radiotherapia y quimioterapia asociadas]. Prensa Medica Argentina 1986;73(3):100-3.
26. Dawel M, Brock A, Prager W, Pohlmann S, Schiller S. Simulatenous chemoradiotherapy with carboplatin in inoperable cervical cancer - Results of a study [Simultane Radiochemotherapie mit Carboplatin beim inoperablen Zervixkarzinom - Ergebinisse einer Studie]. Strahlentherapie Und Onkologie 1997;173(11):545.
27. Fernandez DJ, Vidyasagar MS, Rao KK, Shenoy A, Kasturi DP. Synchronous 5-fluorouracil, mitomycin-c and radiation therapy in the treatment of locally advanced carcimoma od the cervix. Proceedings of the 16th Annual Meeting of the Association of Radiation Oncologists of India 1995;Kerala:97-103.
28. Hernandez JRA, Rafael de la Huerta S, Canfield FM, Orozco AF. Clinical stage III cervical cancer: treatment with combined chemotherapy and radiotherapy [Cáncer cervicouterino. Etapa clínica III. Tratamiento combinado de radioterapia quimioterapia.]. Ginecología y Obstetricia De Mexico 1991;59:238-42.
29. Lira-Puerto R, De la Huerta R, Cortes H, Fernandez A, Silva A, Martinez R, et al.Cisplatin (CDDP) plus radiotherapy (RT) versus radiotherapy alone in locally advanced cervical cancer. Proceedings of the American Society of Clinical Oncology 1990;9:A633.
30. Singh P, Dharmalingham SK, Tan MK, Tan CK. Chemotherapy - radiotherapy combination in the treatment of carcinoma of the cervix. Southeast Asian Journal of Tropical Medicine and Public Health 1985;16(4):665-8.
31. Singh TT, Singh IY, Sharma DT, Singh N. Role of chemoradiation in advanced cervical cancer. Indian Journal of Cancer 2003;40(3):101-7.
32. Tseng C-J, Chang C-T, Lai C-H, Soong Y-K, Hong J-H, Tang SG, et al.A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the cervix. Gynecologic Oncology 1997;66:52-8.
33. Wong LC, Choo YS, Choy D, Sham JST, Ma HK. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecologic Oncology 1989;35:159-63.
34. Wong LC, Ngan ANY, Cheung ANY, Cheng DKL, Ng TY, Choy DTK. Chemoradiation and adjuvant chemotherapy in cervical cancer. Journal of Clinical Oncology 1999;17(7):2055-60.
35. Advanced Bladder Cancer Overview Collaboration. Does neo-adjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomised clinical trials. British Journal of Urology 1995;75:206-13.
36. Arbyn M, Raifu AO, Autier P, Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Annals of Oncology 2007;doi:10:1093/annonc/mdm079.
37. Australian Institute of Health and Welfare. Cervical Screening in Australia 2004-2005. Cancer Series No. 38. Cat no. CAN 33.(Canberra: AIHW).
38. Canadian Cancer Society / National Cancer Institute of Canada. Canadian Cancer Statistics 2007; Vol. Toronto, Canada.
39. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
40. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17-36.
41. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al.Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
42. Green J, Kirwan J, Tierney J, Vale CL, Symonds PR, Fresco LL, et al.Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database of Systematic Reviews 2005, Issue (Issue 3):CD002225.pub2. [DOI: 10.1002/14651858.CD002225.pub2].
43. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
44. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-81.
45. Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al.Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clinical Oncology 2002;14:203-12.
46. Mitra D, Ghosh B, Kar A, Basu S, Deb AR, Sur PK. Role of chemoradiotherapy in advanced carcinoma cervix. Journal of the Indian Medical Association 2006;104(8):432, 434, 436.
47. National Cancer Institute.NCI Issues Clinical Announcement on Cervical Cancer: Chemotherapy plus Radiation Improves Survival. [Web page] Available at http://www.nih.gov/news/pr/feb99/nci22.htm 1999.
48. Parkin DM, Bray F, Ferlay J, Pisani Paola. Global cancer statistics, 2002. CA- Cancer J Clinicians 2005;55:74-108.
49. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. Chichester: John Wiley and Sons Ltd, 1995.
50. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
51. Pearcey R, Miao Q, Kong W, Zhang-Salomens J, MacKillop WJ. Impact of adoption of Chemoradiotherapy on the outcome of cervical cancer in Ontario: Results of a population based cohort study. Journal of Clinical Oncology 2007;25(17):2383-8.
52. Ries LAG, Harkins D, Krapcho M, et al.SEER Cancer Statistics Review, 1975-2003. National Cancer Institute, Bethseda, MD.Based on November 2005 SEER data submission, (posted to the SEER website, 2006).
53. Stewart LA, Clarke MJ, on behalf of the Cochrane Working Party Group on Meta-analysis using Individual Patient Data. Practical methodology of meta-analyses (overviews) using updated individual patient data. Statistics in Medicine 1995;14:2057-79.
54. Symonds RP, Kirwan J, Williams CJ, Tierney JF, Green J, Collingwood M. Concomitant hydroxurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review. Cochrane Database of Systematic Reviews 2004, Issue 1:CD003918.
55. Symonds RP, Collingwood M, Kirwan J, Humber CE, Tierney JF, Green JA, et al.Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review. Cancer Treatment Reviews 2004;30:405-14.
56. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8(1):16.
57. Trimble E, Gius D, Harlan LC. Impact of NCI announcement upon use of chemoradiation for women with cervical cancer. Journal of Clinical Oncology 2007;25(18S):5537.
58. Yusuf S, Peto R, Lewis JA, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27:335-71.
59. Chemoradiotherapy for cervical cancer meta-analysis collaboration. Reducing Uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomised trials. Journal of Clinical Oncology 2008;26:5802-12.